Josh Payne, the chief executive of Nscale, raised $2 billion from investors. Sheryl Sandberg, the former Facebook executive, ...
Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results